Drew Burdon

Private Equity Investor chez EQT Life Sciences Group BV

Profil

Drew Burdon is a Partner in the EQT Life Sciences team.
Drew worked for LSP from 2019 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Prior to joining LSP, Drew worked for 13 years across R&D, commercial/strategy and most recently as a Director of Corporate Development at Smith & Nephew in London, UK.
Prior to Smith & Nephew, Drew was a Senior Scientific Officer, at Cancer Research UK in Leeds, UK.
Drew holds a BSc (Hons) In Medical Biochemistry and a PhD in Cell and Molecular Biology, both from the University of Leicester (UK), as-well as an MBA from the Open University (UK).

Postes actifs de Drew Burdon

Sociétés	Poste	Début
EQT Life Sciences Group BV	Private Equity Investor	28/02/2022

Anciens postes connus de Drew Burdon

Sociétés	Poste	Fin
LSP Management Group BV	Private Equity Investor	28/02/2022

Formation de Drew Burdon

University of Leicester	Doctorate Degree
The Open University Business School	Masters Business Admin